MENU
GHRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

GH Research (GHRS) Ownership - Who owns GH Research?

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more

Profile

Industry
N/A
Address
Dawson Street
Phone
+353 14378334
Employees
49
Web
https://www.ghres.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
849.79M
P/E Ratio
N/A
Total Cash
291.35M
Projected Growth
N/A
Total Debt
658K
Revenue
N/A
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash/Share
4.70
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

GHRS
Capitalization
850M
P/E Ratio
N/A
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash
291M
Total Cash/Share
4.70
Total Debt
658K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
310M
P/B Ratio
2.74
Cash Flow
N/A
Earnings
-0.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.55M
Current Ratio
29.71
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-41.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-15.65
Shares Held By Institutions
231M
Shares Outstanding - Current
62M
Total Liabilities
10.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
95.714
View a ticker or compare two or three
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Dawson Street
Phone
+353 14378334
Employees
49
Web
https://www.ghres.com